Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "cardiac"

240 News Found

Modular ATP study of the mCRM System meets primary safety and efficacy endpoints
Clinical Trials | May 21, 2024

Modular ATP study of the mCRM System meets primary safety and efficacy endpoints

Additional data from APPRAISE ATP trial reinforce modular therapy approach


OMRON Healthcare India and AliveCor partner to improve heart healthcare in India
Healthcare | May 11, 2024

OMRON Healthcare India and AliveCor partner to improve heart healthcare in India

These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more


Zydus Lifesciences Q3 FY24 PAT up 26.8%
News | February 10, 2024

Zydus Lifesciences Q3 FY24 PAT up 26.8%

Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.


100 bedded Yoga & Naturopathy Hospital to come up in Dibrugarh
News | January 30, 2024

100 bedded Yoga & Naturopathy Hospital to come up in Dibrugarh

Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy


Indian Red Cross Society and Cadila to launch training of 50,000 students for CPR and First Aid
News | January 29, 2024

Indian Red Cross Society and Cadila to launch training of 50,000 students for CPR and First Aid

The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state


Bayer, Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India
News | January 17, 2024

Bayer, Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India

Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa


Glenmark to launch biosimilar of anti-diabetic drug Liraglutide in India
News | January 03, 2024

Glenmark to launch biosimilar of anti-diabetic drug Liraglutide in India

Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs


Max Healthcare acquires 550 bedded Sahara Hospital, Lucknow
Healthcare | December 09, 2023

Max Healthcare acquires 550 bedded Sahara Hospital, Lucknow

This acquisition marks Max Healthcare's entry into Lucknow